Artelon provides kinematic reinforcement of tendon and ligament reconstruction using specifically designed bio-textiles.
Artelon has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in May 2023.
Artelon's investors include Vensana Capital.
Artelon is headquartered in Marietta, United States.
Artelon provides kinematic reinforcement of tendon and ligament reconstruction using specifically designed bio-textiles.
Artelon is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artelon — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/artelon. Accessed November 13, 2026.
VCBacked. (2023). Artelon — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/artelon
{{cite web |title=Artelon — Funding & Investors |url=https://www.vcbacked.co/company/artelon |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Artelon? Request a listing update